RESUMO
The prevalence and risk factors for gut carriage of antimicrobial-resistant Escherichia coli among individuals living in the community in Rio de Janeiro, Brazil, are unknown. The aim of this study was to determine the prevalence of colonization with antimicrobial-resistant E. coli, including isolates producing ESBL and harboring plasmid-mediated quinolone resistant (PMQR) genes in this community. We performed a cross-sectional study and analyzed fecal specimens of individuals attending outpatient clinics in the city from January 2015 to July 2019. We investigated susceptibility to antimicrobial agents by disc diffusion tests and used PCR to determine ESBL types, PMQR, and the virulence genes that characterize an isolate as extraintestinal pathogenic E. coli (ExPEC). Among the 623 subjects, 212 (34%) carried an isolate resistant to at least one of the tested antimicrobial agents, with the highest frequencies of resistance to ampicillin (26%), trimethoprim-sulfamethoxazole (19%), cefazolin (14%), and ciprofloxacin (CIP, 9%). In addition, 13% (81) of subjects carried a multidrug-resistant-E. coli (MDR-E), including 47 (8% of all isolates) ESBL-producing E. coli (ESBL-E), mainly of CTX-M-8 (15, 32%) and CTX-M-15 (9, 20%) types. PMQR genes were present in 7% (42) of all isolates, including 60% (32) of the 53 resistant to CIP. Previous use of antimicrobial agents, particularly fluoroquinolones, was a risk factor for colonization with MDR-E (25%, 20/81 vs 13%, 70/542, p = 0.01), ESBL-E (28%, 13/47, vs 13%, 77/576, p = 0.01), and resistance to CIP (26%, 14/53, vs 12%, 70/570, p = 0.01). The most pathogenic phylogroups B2, C, and D were 37% of the MDR-E, 30% of the ESBL-E, 38% of the CIP-resistant, and 31% of PMQR gene carrying E. coli isolates. We show that carriage of MDR-E (mostly ESBL-E) reached high levels in the community in Rio de Janeiro, increased by the selection of antimicrobial agents. Much of the resistant E. coli isolates are potential pathogenic strains. The widespread use of antimicrobial agents during the COVID-19 pandemic in Brazil may have worsened this picture.
Assuntos
COVID-19 , Infecções por Escherichia coli , Antibacterianos/farmacologia , Brasil/epidemiologia , Estudos Transversais , Farmacorresistência Bacteriana Múltipla , Escherichia coli , Infecções por Escherichia coli/epidemiologia , Infecções por Escherichia coli/microbiologia , Humanos , Testes de Sensibilidade Microbiana , Pandemias , SARS-CoV-2 , beta-Lactamases/genéticaRESUMO
This is the first detection and genomic analysis of an OXA-181-carbapenemase-producing E. coli in Brazil, from a traveler returning from Sub-Saharan Africa. The ST167 isolate carries blaOXA-181 inserted in an IncX3 plasmid. This report illustrates the potential role of travelers as silent vectors for dissemination of high-risk resistant clones.
Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana Múltipla/genética , Proteínas de Escherichia coli/genética , Escherichia coli/genética , beta-Lactamases/genética , Adulto , África Subsaariana , Brasil/epidemiologia , Fezes/microbiologia , Genoma Bacteriano , Humanos , Masculino , Testes de Sensibilidade Microbiana , PlasmídeosRESUMO
BACKGROUND: Antimicrobial resistance is increased by international mobility. We present data about intestinal colonization of travelers departing from a middle-income country. METHODS: Travelers were recruited from 2015 to 2019, collected an anal stool specimen and answered a questionnaire before and after travel. Enterobacterales isolates were investigated for antimicrobial resistance; extended-spectrum beta-lactamase (ESBL) and carbapenemase production; plasmid-encoded cephalosporinases (pAmpC), plasmid-mediated quinolone resistance (PMQR) and mcr genes by PCR and sequencing; and association with travel related variables. RESULTS: Among 210 travelers, 26 (12%) carried multidrug-resistant Enterobacterales (MDR-E) and 18 (9%) ESBL-producing Enterobacterales (ESBL-E) before travel, with an increased prevalence from 1% to 11% over the study years. Acquisition of MDR-E and ESBL-E occurred in 59 (32%) and 43 (22%) travelers, respectively, mostly blaCTX-M-15 carrying Escherichia coli. One traveler acquired one isolate carrying blaOXA-181 gene, and two others, isolates carrying mcr-1. PMQR were detected in 14 isolates of returning travelers. The risk of MDR-E acquisition was higher in Southeast Asia and the Indian subcontinent, and after using antimicrobial agents. CONCLUSION: We describe an increasing pre-travel prevalence of ESBL-E colonization in subjects departing from this middle-income country over time. Travel to known risk areas and use of antimicrobial agents during travel were associated with acquisition of MDR-E. Travel advice is critical to mitigating this risk, as colonization by MDR-E may raise the chances of antimicrobial-resistant infections.
Assuntos
Antibacterianos , Viagem , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Brasil/epidemiologia , Farmacorresistência Bacteriana/genética , Humanos , Doença Relacionada a Viagens , beta-Lactamases/genéticaRESUMO
INTRODUCTION: Malaria is the main cause of death by infection among travelers and is preventable through a combination of chemoprophylaxis and personal protective measures. METHODS: Travelers were interviewed by phone 28-90 days after returning, to assess adherence to pre-travel advice for malaria prevention. RESULTS: A total 57 travelers were included. Adherence to chemoprophylaxis was significantly higher among participants prescribed mefloquine (n=18; 75%) than doxycycline (n=14; 45%). Adherence to mosquito repellent and bed net use was 65% and 67%, respectively. CONCLUSIONS: Adherence to malaria prophylaxis was lower than expected. Further studies testing innovative approaches to motivate travelers' compliance are required.
Assuntos
Antimaláricos/uso terapêutico , Doxiciclina/uso terapêutico , Malária/tratamento farmacológico , Malária/prevenção & controle , Adesão à Medicação/estatística & dados numéricos , Mefloquina/uso terapêutico , Profilaxia Pré-Exposição/estatística & dados numéricos , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , ViagemRESUMO
Abstract INTRODUCTION: Malaria is the main cause of death by infection among travelers and is preventable through a combination of chemoprophylaxis and personal protective measures. METHODS: Travelers were interviewed by phone 28-90 days after returning, to assess adherence to pre-travel advice for malaria prevention. RESULTS: A total 57 travelers were included. Adherence to chemoprophylaxis was significantly higher among participants prescribed mefloquine (n=18; 75%) than doxycycline (n=14; 45%). Adherence to mosquito repellent and bed net use was 65% and 67%, respectively. CONCLUSIONS: Adherence to malaria prophylaxis was lower than expected. Further studies testing innovative approaches to motivate travelers' compliance are required.
Assuntos
Humanos , Masculino , Feminino , Adulto , Mefloquina/uso terapêutico , Doxiciclina/uso terapêutico , Adesão à Medicação/estatística & dados numéricos , Profilaxia Pré-Exposição/estatística & dados numéricos , Malária/prevenção & controle , Malária/tratamento farmacológico , Antimaláricos/uso terapêutico , Viagem , Pessoa de Meia-IdadeRESUMO
Providing advice for travelers embarking on long-term trips poses a challenge in travel medicine. A long duration of risk exposure is associated with underuse of protective measures and poor adherence to chemoprophylaxis, increasing the chances of acquiring infections. Recently, in our clinic, we observed an increase in the number of travelers undertaking round-the-world trips. These individuals are typically aged around 32 years and quit their jobs to embark on one-to-two-year journeys. Their destinations include countries in two or more continents, invariably Southeast Asia and Indonesia, and mostly involve land travel and visiting rural areas. Such trips involve flexible plans, increasing the challenge, especially with regard to malaria prophylaxis. Advising round-the-world travelers is time-consuming because of the amount of information that must be provided to the traveler. Advisors must develop strategies to commit the traveler to his/her own health, and verify their learnings on disease-prevention measures. Contacting the advisor after the appointment or during the trip can be helpful to clarify unclear instructions or diagnosis made and prescriptions given abroad. Infectious diseases are among the most frequent problems affecting travelers, many of which are preventable by vaccines, medicines, and precautionary measures. The dissemination of counterfeit medicines, particularly antibiotics and antimalarial medicines, emphasizes the need for travelers to carry medicines that they may possibly need on their trip. Additional advice on altitude, scuba diving, and other possible risks may also be given. Considering the difficulties in advising this group, we present a review of the main recommendations on advising these travelers.
Assuntos
Controle de Doenças Transmissíveis/métodos , Medicina de Viagem/tendências , Viagem , Controle de Doenças Transmissíveis/tendências , Aconselhamento , HumanosRESUMO
Abstract Providing advice for travelers embarking on long-term trips poses a challenge in travel medicine. A long duration of risk exposure is associated with underuse of protective measures and poor adherence to chemoprophylaxis, increasing the chances of acquiring infections. Recently, in our clinic, we observed an increase in the number of travelers undertaking round-the-world trips. These individuals are typically aged around 32 years and quit their jobs to embark on one-to-two-year journeys. Their destinations include countries in two or more continents, invariably Southeast Asia and Indonesia, and mostly involve land travel and visiting rural areas. Such trips involve flexible plans, increasing the challenge, especially with regard to malaria prophylaxis. Advising round-the-world travelers is time-consuming because of the amount of information that must be provided to the traveler. Advisors must develop strategies to commit the traveler to his/her own health, and verify their learnings on disease-prevention measures. Contacting the advisor after the appointment or during the trip can be helpful to clarify unclear instructions or diagnosis made and prescriptions given abroad. Infectious diseases are among the most frequent problems affecting travelers, many of which are preventable by vaccines, medicines, and precautionary measures. The dissemination of counterfeit medicines, particularly antibiotics and antimalarial medicines, emphasizes the need for travelers to carry medicines that they may possibly need on their trip. Additional advice on altitude, scuba diving, and other possible risks may also be given. Considering the difficulties in advising this group, we present a review of the main recommendations on advising these travelers.
Assuntos
Humanos , Viagem , Controle de Doenças Transmissíveis/métodos , Medicina de Viagem/tendências , Controle de Doenças Transmissíveis/tendências , AconselhamentoRESUMO
Sporotrichosis is the most common subcutaneous mycosis in South America and its association with zoonotic transmission remains a relevant public health problem in Rio de Janeiro, Brazil. The disease most commonly presents as subacute or chronic cutaneous lesions, although dissemination to various organs and systems occurs in rare cases, mainly in immunosuppressed individuals. This report describes a case of sporotrichosis with severe bone and subcutaneous damage in an immunocompetent patient who did not exhibit the characteristic skin lesions of sporotrichosis, including ulcers, nodules, and lymphangitis.
Assuntos
Osteomielite/microbiologia , Esporotricose/complicações , Adulto , Humanos , Imunocompetência , Imageamento por Ressonância Magnética , Masculino , Osteomielite/diagnóstico , Esporotricose/diagnósticoRESUMO
Abstract Sporotrichosis is the most common subcutaneous mycosis in South America and its association with zoonotic transmission remains a relevant public health problem in Rio de Janeiro, Brazil. The disease most commonly presents as subacute or chronic cutaneous lesions, although dissemination to various organs and systems occurs in rare cases, mainly in immunosuppressed individuals. This report describes a case of sporotrichosis with severe bone and subcutaneous damage in an immunocompetent patient who did not exhibit the characteristic skin lesions of sporotrichosis, including ulcers, nodules, and lymphangitis.
Assuntos
Humanos , Masculino , Adulto , Osteomielite/microbiologia , Esporotricose/complicações , Osteomielite/diagnóstico , Esporotricose/diagnóstico , Imageamento por Ressonância Magnética , ImunocompetênciaRESUMO
Leishmania RNA virus (LRV) has been shown to be a symbiotic component of Leishmania parasites in South America. Nested retro-transcription polymerase chain reaction was employed to investigate LRV1 presence in leishmaniasis lesions from Brazil. In endemic areas of Rio de Janeiro (RJ), no LRV1 infection was observed even with mucosal involvement. LRV1 was only detected in Leishmania (V.) guyanensis cutaneous lesions from the northern region, which were obtained from patients presenting with disease reactivation after clinical cure of their primary lesions. Our results indicated that the severity of leishmaniasis in some areas of RJ, where Leishmania (V.) brazi-liensis is the primary etiological agent, was not associated with Leishmania LRV1 infection.
Assuntos
Leishmania braziliensis/virologia , Leishmaniose Cutânea/parasitologia , Vírus de RNA/genética , Brasil , Feminino , Humanos , Reação em Cadeia da Polimerase , Vírus de RNA/classificação , RNA Viral/genética , Índice de Gravidade de DoençaRESUMO
Leishmania RNA virus (LRV) has been shown to be a symbiotic component of Leishmania parasites in South America. Nested retro-transcription polymerase chain reaction was employed to investigate LRV1 presence in leishmaniasis lesions from Brazil. In endemic areas of Rio de Janeiro (RJ), no LRV1 infection was observed even with mucosal involvement. LRV1 was only detected in Leishmania (V.) guyanensis cutaneous lesions from the northern region, which were obtained from patients presenting with disease reactivation after clinical cure of their primary lesions. Our results indicated that the severity of leishmaniasis in some areas of RJ, where Leishmania (V.) brazi-liensis is the primary etiological agent, was not associated with Leishmania LRV1 infection.
Assuntos
Feminino , Humanos , Leishmania braziliensis/virologia , Leishmaniose Cutânea/parasitologia , Vírus de RNA/genética , Brasil , Reação em Cadeia da Polimerase , Vírus de RNA/classificação , RNA Viral/genética , Índice de Gravidade de DoençaRESUMO
Infection of humans with Leishmania braziliensis typically results in localized cutaneous leishmaniasis (LCL). Rarely, after months or years of apparent clinical cure, some patients develop the destructive mucosal leishmaniasis (ML). ML results from L. braziliensis dissemination, probably via phagocytic cells. As the preferred cells for Leishmania spp. colonization, macrophages are critical to infection control, and may contribute to parasite dissemination. However, the host factors that determine this outcome are unknown. Matrix metalloproteinase 9 (MMP-9) is known to be important for immune cell migration, macrophage recruitment, and effective granuloma formation. Moreover, MMP-9 has been involved in Mycobacterium tuberculosis dissemination. Here, we demonstrate that in vitro infection of human macrophages with L. braziliensis increased the secretion and activation of MMP-9. We also demonstrate that macrophages from healthy cured individuals with previous history of ML had increased MMP-9 activity compared to LCL cured individuals. These findings may represent a fundamental difference in host innate immunity that could contribute to the clinical leishmaniasis presentation.
Assuntos
Leishmania braziliensis/imunologia , Leishmania braziliensis/patogenicidade , Leishmaniose Mucocutânea/patologia , Macrófagos/parasitologia , Metaloproteinase 9 da Matriz/metabolismo , Adolescente , Adulto , Idoso , Animais , Humanos , Leishmaniose Mucocutânea/imunologia , Leishmaniose Mucocutânea/parasitologia , Macrófagos/enzimologia , Pessoa de Meia-Idade , Adulto JovemRESUMO
A Leishmaniose Tegumentar Americana (LTA) é uma doença que se caracteriza pela presença de lesões cultâneas (LCL) e, em um número pequeno de pacientes, pelo desenvolvimento de lesão mucosa (ML). A evolução clínica e a resposta ao tratamento dependem de múltiplos fatores, incluindo o equilíbrio entre as citocinas Th1 e Th2, influenciando no controle parasitário e na extensão da lesão. Nesse equilíbrio complexo é possível que outras citocinas inflamatórias como IL-17 e IL-18, bem como fatores que influenciem na diferenciação de queratinócitos e nos processos inflamatórios da pele, como o sistema Notch, também possam se relacionar ao prognóstico das lesões. IL-18 é uma potente citocina indutora de IFN-gama, já tendo sido observado efeito protetor em doenças por protozoários. IL-17 é produzida por uma linhagem de células T descritas mais recentemente, que são consideradas essenciais em processos inflamatórios de vários tecidos e em doenças auto-imunes. O sistema de sinalização Notch é composto por um grupo de proteínas transmembrana que regulam processos decisórios em diversos tecidos, tanto no período embrionário como na vida adulta, incluindo a diferenciação de queratinócitos e de linfócitos T, na dependência do ligante envolvido em sua ativação (Delta-like DLL1/DLL3/DLL4 ou Jagged 1 e 2). Estudamos a expressão das proteínas do sistema Notch e das citocinas IL-17 e IL-18 em lesões e sangue de pacientes com LTA causada por Leishmania (Viannia) braziliensis, comparando os níveis de expressão de acordo com o tempo de evolução das lesões, diâmetro da reação de Montenegro e resposta ao tratamento. As lesões cutâneas de LTA apresentam maior expressão de receptores Notch que a pele normal...